Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 800 3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

BillionerOfKing Apr. 28 at 5:03 PM

$REVB Current Stock Price: $1.15

0 · Reply

CyrusTrade Apr. 28 at 4:51 PM

$REVB every investor stuck in this black hole while mgmt is burning money towards next dilution and RS till eventual delisting

0 · Reply

revuelto Apr. 22 at 9:30 PM

$REVB while REVB.cash_burn: REVB.raise_capital() shareholders.get_diluted() if no_revenue and no_confidence: print("NASDAQ delisting incoming") break

0 · Reply

Buysellbkr Apr. 16 at 4:17 PM

$REVB on watch here

0 · Reply

jsmith14 Apr. 15 at 6:28 PM

$REVB moving up on technicals

0 · Reply

CyrusTrade Apr. 14 at 8:25 PM

$REVB is it delisting? Why the broker says "this security can only be liquidated."

4 · Reply

Schizoo Apr. 13 at 2:32 PM

$REVB time to enter?

0 · Reply

Shodan84 Apr. 10 at 6:36 AM

$REVB

0 · Reply

focafoca99 Apr. 6 at 6:41 PM

$REVB formed an acute kidney injury advisory board ahead of its planned Phase 2/3 AKI trial.

0 · Reply

BUKUDATBULL Apr. 6 at 1:07 PM

GONNA HAVE MY PEEPERZ LOCKED 🔒 DOWN ON THESE "POTENTIALZ4PROFITZ " $JAGX $REVB $FRGT $AIXI And also "HTCR" They just did a BIG -R/S - So yeh would keep a good eye on this one it's got some weird juju-or something about it i think/got a bit of a tingling or 🤷 Maybe 🤔 i just got crabs /need to get to the doctor and stop pretending it's my intuition ..... 😜💋 JK BUT seriously though my 🥜 z -CAN U PLEASE 🙏 GET OFF THEM 😎✌️(DUECES/douches)⏲️Times ⬆️⏰😬good🍀

0 · Reply

Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

Mar 30, 2026, 9:00 AM EDT - 4 weeks ago

Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study

Mar 24, 2026, 9:00 AM EDT - 5 weeks ago

REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

Mar 19, 2026, 9:00 AM EDT - 5 weeks ago

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

Feb 26, 2026, 4:15 PM EST - 2 months ago

Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

Jan 26, 2026, 9:55 AM EST - 3 months ago

Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026

Jan 23, 2026, 2:10 PM EST - 3 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds

Jan 21, 2026, 8:30 AM EST - 3 months ago

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

Jan 14, 2026, 9:00 AM EST - 3 months ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

Jan 12, 2026, 5:00 PM EST - 3 months ago

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jan 7, 2026, 9:00 AM EST - 4 months ago

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

Dec 1, 2025, 9:00 AM EST - 5 months ago

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

Nov 20, 2025, 9:00 AM EST - 5 months ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

Nov 6, 2025, 4:15 PM EST - 6 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Oct 29, 2025, 9:00 AM EDT - 6 months ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

Oct 15, 2025, 5:00 PM EDT - 7 months ago

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

Sep 11, 2025, 8:30 AM EDT - 8 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

Sep 10, 2025, 7:20 AM EDT - 8 months ago

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Sep 9, 2025, 4:55 PM EDT - 8 months ago

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

Sep 9, 2025, 8:00 AM EDT - 8 months ago

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

Aug 8, 2025, 6:30 AM EDT - 9 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Jul 24, 2025, 9:00 AM EDT - 9 months ago

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Jul 16, 2025, 9:00 AM EDT - 10 months ago

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Jul 1, 2025, 5:26 PM EDT - 10 months ago

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

May 29, 2025, 4:05 PM EDT - 11 months ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 11 months ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 1 year ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 1 year ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 1 year ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 1 year ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 1 year ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 1 year ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 2 years ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 2 years ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 2 years ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 2 years ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

BillionerOfKing Apr. 28 at 5:03 PM

$REVB Current Stock Price: $1.15

0 · Reply

CyrusTrade Apr. 28 at 4:51 PM

$REVB every investor stuck in this black hole while mgmt is burning money towards next dilution and RS till eventual delisting

0 · Reply

revuelto Apr. 22 at 9:30 PM

$REVB while REVB.cash_burn: REVB.raise_capital() shareholders.get_diluted() if no_revenue and no_confidence: print("NASDAQ delisting incoming") break

0 · Reply

Buysellbkr Apr. 16 at 4:17 PM

$REVB on watch here

0 · Reply

jsmith14 Apr. 15 at 6:28 PM

$REVB moving up on technicals

0 · Reply

CyrusTrade Apr. 14 at 8:25 PM

$REVB is it delisting? Why the broker says "this security can only be liquidated."

4 · Reply

Schizoo Apr. 13 at 2:32 PM

$REVB time to enter?

0 · Reply

Shodan84 Apr. 10 at 6:36 AM

$REVB

0 · Reply

focafoca99 Apr. 6 at 6:41 PM

$REVB formed an acute kidney injury advisory board ahead of its planned Phase 2/3 AKI trial.

0 · Reply

BUKUDATBULL Apr. 6 at 1:07 PM

0 · Reply

revuelto Apr. 2 at 10:56 PM

$REVB not bad…I was expecting it to dip below $1 pretty quickly here…..

0 · Reply

PureTrades Mar. 31 at 6:58 PM

$REVB Exactly

0 · Reply

Krull99 Mar. 31 at 4:21 PM

$REVB $FATN $ELAB $ABVE 💪💪💪

0 · Reply

jsmith14 Mar. 31 at 3:21 PM

$REVB looks like this may be reversing, significant amount of cash on hand here.

0 · Reply

Kindrs2rud Mar. 31 at 3:04 PM

$REVB This guy is a degenerate Gambler, his kind put money into a stock and then SPAM THE FK out of it, to try and pump it. If you see this account starting to spam YOUR particular stock? Time to GTFO!

1 · Reply

Shodan84 Mar. 31 at 8:42 AM

$REVB Another hidden diamond

0 · Reply

PureTrades Mar. 31 at 5:01 AM

$REVB Major bullish move coming. Extremely undervalued here.

1 · Reply

SPARTANVI Mar. 30 at 10:50 PM

$REVB Primed here , New highs

0 · Reply

VFVENDETTA Mar. 30 at 10:29 PM

$REVB Agreed 5$ cash per share to be more precise Has nice catalyst ahead ⏰️🔥

0 · Reply

Zokbar Mar. 30 at 10:24 PM

$REVB this is one of the few I’m in for the ride - $4 cash per shares, warrants at $3.45, no need to raise til 2027, a massive market for the drug, and positive results. might take a minute to get enough eyes here but when it does ….

0 · Reply

VFVENDETTA Mar. 30 at 10:19 PM

$REVB Baked hard with this guy Joining $POLA too

0 · Reply

SPARTANVI Mar. 30 at 10:17 PM

$REVB Banger so far $POLA starting too

0 · Reply

Market Cap	4.35M
Revenue (ttm)	0.00
Net Income (ttm)	-8.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	41,900
Avg Vol	87,956
Day's Range	N/A - N/A
Shares Out	3.72M
Stochastic %K	55%
Beta	-0.17
Analysts	Strong Sell
Price Target	$19.25